A Novel Intravascular Lithotripsy System in Severely Calcified Coronary Lesions: The Prospective COronary CAlcified Lesion Lithotripsy Procedure (COCALP) Study

Abstract

Intravascular lithotripsy (IVL) is a promising therapy for calcified coronary lesions. This study evaluated the safety and effectiveness of a novel IVL system. The COronary CAlcified Lesion Lithotripsy Procedure (COCALP) study (No. ChiCTR2300073280) was a prospective, multicenter, single-arm trial involving 266 patients with severely calcified coronary lesions. The primary endpoint was procedural success, defined as successful stent implantation with ≤30% residual stenosis and no in-hospital major adverse cardiovascular events (MACE). In a subgroup, calcium morphology was evaluated by optical coherence tomography (OCT) assessment. A total of 266 patients were included. The procedural success rate was 97.4% (95% confidence interval [CI]: 0.947–0.989), with the lower limit of the CI exceeding the prespecified performance goal (p < 0.001). No MACE occurred intraoperatively. During hospitalization, MACE occurred in five patients (1.9%), all of which were myocardial infarctions. MACE rates at 1 and 6 months were 2.3 and 3.4%, respectively. In the OCT subgroup (n = 76), IVL induced a 76.8% rate of calcification fracture. The minimal lumen area increased from 1.77 ± 0.72 to 2.59 ± 1.11 mm² following IVL (p < 0.001), and further expanded to 5.22 ± 1.69 mm² poststenting (p < 0.001). The novel IVL system demonstrated high effectiveness and safety, supporting its use for treating severely calcified coronary lesions and enhancing stent implantation success.

Keywords

effectiveness / intravascular lithotripsy / major adverse cardiovascular events / optical coherence tomography / safety / severe coronary calcification

References

[1] X. Zhou, L. Yu, Y. Zhao, and J. Ge, “Panvascular Medicine: An Emerging Discipline Focusing on Atherosclerotic Diseases,” European Heart Journal 43, no. 43 (2022): 4528-4531.

[2] Y. Hu, Y. Zhao, N. Dai, H. Lu, and J. Ge, “Unwavering Excellence: How to be a Competent Cardiovascular Doctor in “Panvascular Medicine +”,” The Innovation 4, no. 5 (2023): 100489.

[3] M. Wong, Y. Dai, and J. Ge, “Pan-vascular Disease: What We Have Done in the Past and What We Can Do in the Future?,” Cardiol Plus 9, no. 1 (2024): 1-5.

[4] Y. Hu, Y. Zhao, P. Li, H. Lu, H. Li, and J. Ge, “Hypoxia and Panvascular Diseases: Exploring the Role of Hypoxia-inducible Factors in Vascular Smooth Muscle Cells Under Panvascular Pathologies,” Science Bulletin 68, no. 17 (2023): 1954-1974.

[5] Y. Zhao, W. Xiong, C. Li, et al., “Hypoxia-induced Signaling in the Cardiovascular System: Pathogenesis and Therapeutic Targets,” Signal Transduction and Targeted Therapy 8, no. 1 (2023): 431.

[6] E. Barbato, E. Shlofmitz, A. Milkas, R. Shlofmitz, L. Azzalini, and A. Colombo, “State of the Art: Evolving Concepts in the Treatment of Heavily Calcified and Undilatable Coronary Stenoses—From Debulking to Plaque Modification, a 40-year-long Journey,” EuroIntervention 13, no. 6 (2017): 696-705.

[7] J. Yin, R. Wang, H. Chen, et al., “In Vivo Evaluation of Intravascular Lithotripsy in a Healthy porcine Coronary Model,” Catheterization and Cardiovascular Interventions 101, no. 6 (2023): 1062-1070.

[8] J. B. Ge, L. Ge, Y. Huo, J. Y. Chen, W. M. Wang, and B. Zhang, “Updated Algorithm of Chronic Total Occlusion Percutaneous Coronary Intervention From Chronic Total Occlusion Club China,” Cardiol Plus 6, no. 2 (2021): 81-87.

[9] H. Lu, Y. Hu, Y. Ma, et al., “Exploring Indicators of Success in Chronic Total Occlusion Percutaneous Coronary Intervention With Stingray System-based Antegrade Dissection Re-entry: Insights From Retrospective Analysis,” Catheterization and Cardiovascular Interventions 102, no. 7 (2023): 1210-1221.

[10] J. Cuesta, M. J. Pérez-Vizcayno, B. García Del Blanco, et al., “Long-Term Results of Bioresorbable Vascular Scaffolds in Patients with in-Stent Restenosis,” JACC: Cardiovascular Interventions 17, no. 15 (2024): 1825-1836.

[11] Z. Yang, J. Yin, Y. Hu, et al., “Long-Term Clinical Outcomes of Treatments for in-Stent Chronic Total Occlusions: A Real-World Study Based on Different Strategies of Revascularization,” MedComm - Future Medicine 4, no. 1 (2025): e70011.

[12] National Center For Cardiovascular Diseases The Writing Committee of The Report on Cardiovascular Health and Diseases in China, “Report on Cardiovascular Health and Diseases in China 2023: An Updated Summary,” Biomedical and Environmental Sciences 37, no. 9 (2024): 949-992.

[13] M. Liu, X. He, X. Yang, and Z. Wang, “Interpretation of Report on Cardiovascular Health and Diseases in China 2023,” Chinese General Practice 28, no. 1 (2025): 20-38.

[14] P. Cialdella, S. C. Sergi, G. Zimbardo, et al., “Calcified Coronary Lesions,” European Heart Journal Supplements 25, Supplement_no. C (2023): C68-C73.

[15] C. V. Bourantas, Y. J. Zhang, S. Garg, et al., “Prognostic Implications of Coronary Calcification in Patients With Obstructive Coronary Artery Disease Treated by Percutaneous Coronary Intervention: A Patient-level Pooled Analysis of 7 Contemporary Stent Trials,” Heart 100, no. 15 (2014): 1158-1164.

[16] H. Takebayashi, Y. Kobayashi, G. S. Mintz, et al., “Intravascular Ultrasound Assessment of Lesions With Target Vessel Failure After Sirolimus-eluting Stent Implantation,” American Journal of Cardiology 95, no. 4 (2005): 498-502.

[17] R. Virmani, A. Farb, and A. P. Burke, “Coronary Angioplasty From the Perspective of Atherosclerotic Plaque: Morphologic Predictors of Immediate Success and Restenosis,” American Heart Journal 127, no. 1 (1994): 163-179.

[18] F. Fanelli, A. Cannavale, M. Gazzetti, et al., “Calcium Burden Assessment and Impact on Drug-Eluting Balloons in Peripheral Arterial Disease,” Cardiovascular and Interventional Radiology 37, no. 4 (2014): 898-907.

[19] A. Aksoy, C. Salazar, M. U. Becher, et al., “Intravascular Lithotripsy in Calcified Coronary Lesions: A Prospective, Observational, Multicenter Registry,” Circulation: Cardiovascular Interventions 12, no. 11 (2019): e008154.

[20] P. Généreux, M. V. Madhavan, G. S. Mintz, et al., “Ischemic Outcomes after Coronary Intervention of Calcified Vessels in Acute Coronary Syndromes. Pooled Analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trials,” Journal of the American College of Cardiology 63, no. 18 (2014): 1845-1854.

[21] P. Guedeney, B. E. Claessen, R. Mehran, et al., “Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation,” JACC: Cardiovascular Interventions 13, no. 12 (2020): 1417-1428.

[22] T. Seiler, A. Attinger-Toller, G. M. Cioffi, et al., “Treatment of in-Stent Restenosis Using a Dedicated Super High-Pressure Balloon,” Cardiovascular Revascularization Medicine 46 (2023): 29-35.

[23] I. Moussa, C. Di Mario, J. Moses, et al., “Coronary Stenting after Rotational Atherectomy in Calcified and Complex Lesions. Angiographic and Clinical Follow-up Results,” Circulation 96, no. 1 (1997): 128-136.

[24] A. Shimony, D. Zahger, M. Van Straten, et al., “Incidence, Risk Factors, Management and Outcomes of Coronary Artery Perforation during Percutaneous Coronary Intervention,” American Journal of Cardiology 104, no. 12 (2009): 1674-1677.

[25] P. J. Fitzgerald, T. A. Ports, P. G. Yock, et al., “Contribution of Localized Calcium Deposits to Dissection After Angioplasty. An Observational Study Using Intravascular Ultrasound,” Circulation 86, no. 1 (1992): 64-70.

[26] L. Mauri, R. Bonan, B. H. Weiner, et al., “Cutting Balloon Angioplasty for the Prevention of Restenosis: Results of the Cutting Balloon Global Randomized Trial,” American Journal of Cardiology 90, no. 10 (2002): 1079-1083.

[27] R. Albiero, S. Silber, C. Di Mario, et al., “Cutting Balloon versus Conventional Balloon Angioplasty for the Treatment of in-stent Restenosis: Results of the Restenosis Cutting Balloon Evaluation Trial (RESCUT),” Journal of the American College of Cardiology 43, no. 6 (2004): 943-949.

[28] A. Baumbach, J. A. Bittl, E. Fleck, et al., “Acute Complications of Excimer Laser Coronary Angioplasty: A Detailed Analysis of Multicenter Results. Coinvestigators of the U.S. and European Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Registries,” Journal of the American College of Cardiology 23, no. 6 (1994): 1305-1313.

[29] R. K. Ramana, D. Joyal, D. Arab, et al., “Clinical Experience With Rotational Atherectomy in Patients With Severe Left Ventricular Dysfunction,” Journal of Invasive Cardiology 18, no. 11 (2006): 514-518.

[30] J. Wasiak, J. Law, P. Watson, and A. Spinks, “Percutaneous Transluminal Rotational Atherectomy for Coronary Artery Disease,” Cochrane Database of Systematic Reviews 12, no. 12 (2012): CD003334.

[31] D. D. Hansen, D. C. Auth, R. Vracko, and J. L. Ritchie, “Rotational Atherectomy in Atherosclerotic Rabbit Iliac Arteries,” American Heart Journal 115, no. 1 Pt 1 (1988): 160-165.

[32] A. Kini, J. D. Marmur, S. Duvvuri, G. Dangas, S. Choudhary, and S. K. Sharma, “Rotational Atherectomy: Improved Procedural Outcome With Evolution of Technique and Equipment. Single-center Results of First 1,000 Patients,” Catheterization and Cardiovascular Interventions 46, no. 3 (1999): 305-311.

[33] M. I. Tomey, A. S. Kini, and S. K. Sharma, “Current Status of Rotational Atherectomy,” JACC Cardiovascular Interventions 7, no. 4 (2014): 345-353.

[34] T. Gupta, M. Weinreich, M. Greenberg, A. Colombo, and A. Latib, “Rotational Atherectomy: A Contemporary Appraisal,” Interventional Cardiology 14, no. 3 (2019): 182-189.

[35] Z. A. Ali, T. J. Brinton, J. M. Hill, et al., “Optical Coherence Tomography Characterization of Coronary Lithoplasty for Treatment of Calcified Lesions: First Description,” JACC Cardiovascular Imaging 10, no. 8 (2017): 897-906.

[36] T. J. Brinton, Z. A. Ali, J. M. Hill, et al., “Feasibility of Shockwave Coronary Intravascular Lithotripsy for the Treatment of Calcified Coronary Stenoses,” Circulation 139, no. 6 (2019): 834-836.

[37] Z. A. Ali, H. Nef, J. Escaned, et al., “Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: the Disrupt CAD II Study,” Circulation: Cardiovascular Interventions 12, no. 10 (2019): e008434.

[38] J. M. Hill, D. J. Kereiakes, R. A. Shlofmitz, et al., “Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease,” Journal of the American College of Cardiology 76, no. 22 (2020): 2635-2646.

[39] S. Saito, S. Yamazaki, A. Takahashi, et al., “Intravascular Lithotripsy for Vessel Preparation in Severely Calcified Coronary Arteries Prior to Stent Placement ― Primary Outcomes from the Japanese Disrupt CAD IV Study,” Circulation Journal 85, no. 6 (2021): 826-833.

[40] D. J. Kereiakes, C. Di Mario, R. F. Riley, et al., “Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions: Patient-Level Pooled Analysis of the Disrupt CAD Studies,” JACC Cardiovascular Interventions 14, no. 12 (2021): 1337-1348.

[41] Q. Wang, W. Ma, D. Zhang, et al., “Effectiveness and Safety of a Novel Intravascular Lithotripsy System for Severe Coronary Calcification: The CALCI-CRACK Trial,” Canadian Journal of Cardiology 40, no. 9 (2024): 1657-1667.

[42] G. Zhao and J. Ge, “Preliminary Trail of Domestic Coronary Hydroelectric Shockwave Balloon Catheter in Managing Severe Calcified Lesions,” Chinese Journal of Clinical Medicine 29, no. 4 (2022): 580-584.

[43] F. L. Lazar, A. Ielasi, and B. Cortese, “Safety and Efficacy of Systematic Lesion Preparation With a Novel Generation Scoring Balloon in Complex Percutaneous Interventions: Results From a Prospective Registry,” Minerva Cardiology and Angiology 70, no. 6 (2022): 689-696.

[44] A. Allali, G. Richardt, R. Toelg, et al., “High-speed Rotational Atherectomy versus Modified Balloons for Plaque Preparation of Severely Calcified Coronary Lesions: Two-year Outcomes of the Randomised PREPARE-CALC Trial,” EuroIntervention 18, no. 16 (2023): e1365-e1367.

[45] M. Mhanna, A. Beran, S. Nazir, et al., “Efficacy and Safety of Intravascular Lithotripsy in Calcified Coronary Lesions: A Systematic Review and Meta-Analysis,” Cardiovascular Revascularization Medicine 36 (2022): 73-82.

[46] E. Koifman, M. A. Gaglia, R. O. Escarcega, et al., “Comparison of Transradial and Transfemoral Access in Patients Undergoing Percutaneous Coronary Intervention for Complex Coronary Lesions,” Catheterization and Cardiovascular Interventions 89, no. 4 (2017): 640-646.

[47] M. Valgimigli, A. Gagnor, P. Calabró, et al., “Radial versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: A Randomised Multicentre Trial,” The Lancet 385, no. 9986 (2015): 2465-2476.

[48] K. Thygesen, J. S. Alpert, A. S. Jaffe, et al., “Fourth Universal Definition of Myocardial Infarction (2018),” European Heart Journal 40, no. 3 (2019): 237-269.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.